Tomocube Inc
Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software. In addition, it provides accessories, such as HT-ready 96 well plates; TomoDish that is designed to a… Read more
Tomocube Inc (475960) - Total Assets
Latest total assets as of September 2025: ₩41.04 Billion KRW
Based on the latest financial reports, Tomocube Inc (475960) holds total assets worth ₩41.04 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Tomocube Inc - Total Assets Trend (2021–2024)
This chart illustrates how Tomocube Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Tomocube Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Tomocube Inc's total assets of ₩41.04 Billion consist of 91.9% current assets and 8.1% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩12.69 Billion | 29.1% |
| Accounts Receivable | ₩1.49 Billion | 3.4% |
| Inventory | ₩2.38 Billion | 5.5% |
| Property, Plant & Equipment | ₩2.85 Billion | 6.5% |
| Intangible Assets | ₩567.82 Million | 1.3% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how Tomocube Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tomocube Inc's current assets represent 91.9% of total assets in 2024, a decrease from 92.5% in 2021.
- Cash Position: Cash and equivalents constituted 29.1% of total assets in 2024, down from 60.7% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, unchanged from 1.0% in 2021.
- Asset Diversification: The largest asset category is cash and equivalents at 29.1% of total assets.
Tomocube Inc Competitors by Total Assets
Key competitors of Tomocube Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Tomocube Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Tomocube Inc generates 0.14x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Tomocube Inc is currently not profitable relative to its asset base.
Tomocube Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 15.37 | 6.97 | 6.97 |
| Quick Ratio | 14.06 | 6.02 | 6.02 |
| Cash Ratio | 0.00 | 1.52 | 1.52 |
| Working Capital | ₩32.55 Billion | ₩ 10.19 Billion | ₩ 10.19 Billion |
Tomocube Inc - Advanced Valuation Insights
This section examines the relationship between Tomocube Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 19.21 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 120.5% |
| Total Assets | ₩43.61 Billion |
| Market Capitalization | $293.71 Million USD |
Valuation Analysis
Below Book Valuation: The market values Tomocube Inc's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Tomocube Inc's assets grew by 120.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Tomocube Inc (2021–2024)
The table below shows the annual total assets of Tomocube Inc from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩43.61 Billion | +120.54% |
| 2023-12-31 | ₩19.77 Billion | -21.08% |
| 2022-12-31 | ₩25.06 Billion | -16.38% |
| 2021-12-31 | ₩29.96 Billion | -- |